Dolutegravir and lamivudine and Tegretol (Carbamazepine Tablets)
Determining the interaction of Dolutegravir and lamivudine and Tegretol (Carbamazepine Tablets) and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:CarBAMazepine may significantly reduce the blood levels of dolutegravir, which may make the medication less effective in treating HIV infection. Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact, or you may need a dose adjustment or more frequent monitoring to safely use both medications. Contact your doctor if your condition worsens or you develop new infections during treatment with these medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:GENERALLY AVOID: Coadministration with potent inducers of UGT1A1 and CYP450 3A4 isoenzymes may significantly decrease the plasma concentrations of dolutegravir, which is primarily metabolized by UGT1A1 with some contribution from CYP450 3A4. Dolutegravir is also a substrate of UGT1A3, UGT1A9, and P-glycoprotein in vitro. In 16 study subjects, administration of dolutegravir 50 mg once daily with the potent CYP450 3A4 inducer carbamazepine at a dose of 300 mg twice daily decreased dolutegravir peak plasma concentration (Cmax), systemic exposure (AUC) and trough plasma concentration (Cmin; 24 hours post-dose) by 33%, 49%, and 73%, respectively, compared to administration without carbamazepine. Data are not available for other potent CYP450 3A4 inducers phenytoin, phenobarbital (phenobarbitone), and St. John's wort.
MANAGEMENT: In patients with HIV-1 without integrase inhibitor (INI) resistance, some authorities recommend a dolutegravir dose of 50 mg twice daily for both adults and pediatric patients 12 years of age and older who weigh at least 40 kg when coadministered with potent UGT1A1 and CYP450 3A4 inducers including carbamazepine, phenytoin, phenobarbital, and St. John's Wort. However, other authorities advise that coadministration of dolutegravir with these inducers should be avoided. The safety and efficacy of dosages above 50 mg twice daily have not been evaluated. Alternative treatment combinations that do not include metabolic inducers should be considered whenever possible for INI-experienced patients with certain INI-associated resistance substitutions or clinically suspected INI resistance. In addition, concomitant use of potent UGT1A1 and CYP450 3A4 inducers with fixed-dose combination products containing dolutegravir is not recommended; however, when used in combination with carbamazepine, some authorities advise administration of an additional 50 mg daily dose of dolutegravir approximately 12 hours from the combination product. Local antiretroviral treatment experts should be consulted for current practice.
- "Product Information. Tivicay (dolutegravir)." ViiV Healthcare, Research Triangle Park, NC.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- Cerner Multum, Inc. "Australian Product Information." O 0
- "Product Information. Triumeq (abacavir/dolutegravir/lamiVUDine)." ViiV Healthcare, Research Triangle Park, NC.
- "Product Information. Dovato (dolutegravir-lamivudine)." ViiV Healthcare, Research Triangle Park, NC.
Generic Name: dolutegravir / lamivudine
Brand name: Dovato
Synonyms: Dolutegravir and Lamivudine
Generic Name: carbamazepine
Brand name: Carbatrol, Epitol, Equetro, Tegretol, Tegretol XR, Tegretol, Tegretol XR
Synonyms: Tegretol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dolutegravir and lamivudine-Tegretol XR
- Dolutegravir and lamivudine-Tegrin Medicated
- Dolutegravir and lamivudine-Tegsedi
- Dolutegravir and lamivudine-Tekamlo
- Dolutegravir and lamivudine-Tekral Tablets
- Dolutegravir and lamivudine-Tekturna
- Tegretol (Carbamazepine Tablets)-Dolutegravir and rilpivirine
- Tegretol (Carbamazepine Tablets)-Dolutegravir Sodium
- Tegretol (Carbamazepine Tablets)-Dolutegravir Sodium And Lamivudine
- Tegretol (Carbamazepine Tablets)-Dolutegravir Sodium and Rilpivirine Hydrochloride
- Tegretol (Carbamazepine Tablets)-Dom-Etoposide
- Tegretol (Carbamazepine Tablets)-Donatuss DC Syrup